secwatch.observer — SEC 8-K summary
======================================

Issuer:     Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
CIK:        0001757499
Form:       8-K
Filed at:   2025-11-26T23:59:59+00:00
Accession:  0001493152-25-025082
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 2.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shuttle Pharma acquires AI drug discovery assets for up to $10M; $3M cash paid at close
--------------------------------------------------------------------------------

- Acquired substantially all assets of 1542770 BC Ltd. for total consideration up to $10M: $3M cash at close, $3M in 6 months, $2M in 1 year, plus up to $2M contingent milestone payments.
- Seller may elect to receive future installments in cash or SHPH common stock, capped at 19.99% of outstanding shares without stockholder approval.
- Milestone payments of $1M each require: (1) extension of AI platform for drug-target interaction within 3 months, (2) production of Agentic AI mode for automated drug discovery within 6 months.
- Transaction closed November 20, 2025; Zhitian (Andy) Zhang remains as Key Consultant under non-compete and consulting agreements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757499/000149315225025082/0001493152-25-025082-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757499/000149315225025082/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-025082

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer